Announcements Trials
Browse Landscape

Phase

Phase NA 17Phase 3 3Phase 2 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 1

Conditions

Stomach Neoplasms 1Gynecologic Cancer 1Endometrial Neoplasms 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 362Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Enhanced Recovery After Surgery × Clear all
NCT06732635 2024-12-13

FAST-TRACK

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Phase 3 Completed
68 enrolled
Gynecologic

Endometrial Neoplasms

NCT04596800 2023-10-31

PROPER

Instituto Brasileiro de Controle do Cancer

Phase 3 Unknown
194 enrolled
Gynecologic

Gynecologic Cancer

NCT03160924 2020-05-22

The Impact of Enhanced Recovery After Surgery (ERAS) Program on Clinical and Immunological Outcomes for Minimally-invasive Gastrectomy

Chinese University of Hong Kong

Phase 3 Unknown
50 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡